COMMUNIQUÉS West-GlobeNewswire

Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”
18/06/2026
Event to highlight Nephros’ scalable, service-driven model and differentiated approach beyond filtration products SOUTH ORANGE, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water [...]
Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026
18/06/2026
Complete SAFE KIDNEY II data confirm sustained reduction in viral load and resolution of biopsy-proven BKPyV-associated nephropathy with continued antiviral effect to 38 weeks Systematic literature review demonstrates [...]
Hi*Ball Energy Arrives in the UK, Leading a New Wave of Clean Energy
18/06/2026
Refresh Your Energy with Hi*Ball Sparkling Energy Water, a bold new energy drink powered by natural caffeine and functional ingredients, with zero sugar, zero calories, and zero compromise. Hi*Ball Debuts at Barcode [...]
VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026
18/06/2026
BiTAC-ADC in vitro data, along with initial data from the most advanced BiTAC-TCE program recently presented at the American Association for Cancer Research (AACR) Annual Meeting, underpin the Company’s two viable and [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
18/06/2026
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 18 June 2026 at 14.00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease
18/06/2026
Company to present Phase 3-ready pipeline, 12-LOX platform, and pediatric rare-disease expansion to global pharmaceutical partners at the 2026 BIO International Convention in San Diego Kawasaki disease is the leading [...]
FDA Approves First Single-Dose Generic Treatment for Influenza
18/06/2026
Drug increases ease of use for patients, in advance of flu season Silver Spring, MD, June 18, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir [...]
International Myeloma Foundation’s Black Swan Research Initiative Presents Data and Results of Phase 2 ASCENT Cure Trial at EHA 2026 Congress
18/06/2026
Quadruplet Dara-KRd combination demonstrates high rates of response in high-risk smoldering myeloma patients similar to that observed in NDMM; MRD negativity maintained in nearly two-thirds of patients, with median [...]
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting
18/06/2026
First U.K. case series demonstrates successful use of RECELL GO ® in 17 burn and reconstructive surgery patients Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in [...]
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
18/06/2026
Designation highlights significant regulatory milestone and provides a potential pathway to seven years of U.S. market exclusivity LA JOLLA, CA, June 18, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” [...]
SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets
18/06/2026
Company announces name change to SRX Global in conjunction with transaction closing Company’s stock to remain trading on the NYSE American (“NYSE”) under ticker symbol “SRXH” NORTH PALM BEACH, Fla., June 18, 2026 (GLOBE [...]
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
18/06/2026
K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion NewGen’s expanded stake and exclusive Asia-Pacific agency [...]
CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing
18/06/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding its recent fundraise from [...]
Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026
18/06/2026
MIAMI, June 18, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced [...]
Lite Strategy Leads Strategic Investment in LitVM
18/06/2026
Positions Lite Strategy as a key institutional partner in the development of the Litecoin Ecosystem SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the [...]
Quoin Pharmaceuticals Completes Establishment of Japanese Subsidiary to Advance Commercial Readiness for QRX003
18/06/2026
Supports Quoin’s planned direct commercialization of QRX003 in Japan, one of its three core commercial territories Follows recent grant of Orphan Drug Designation to QRX003 by Japan’s MHLW ASHBURN, Va., June 18, 2026 ( [...]
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
18/06/2026
Georgia’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center; well recognized at the forefront of cancer innovation and discovery nationwide CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- MAIA [...]
LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026
18/06/2026
Company to Loan $6.5 Million Prior to Closing to Fund Order Backlog and Working Capital Needs – Combined Company to be Renamed NOMAD Power Solutions, Inc. and Trade Under a New Ticker Symbol BOCA RATON, Fla. & [...]
COSCIENS Biopharma Inc. Announces Results of Shareholder Meeting and Appointment of Full-Time CEO
18/06/2026
TORONTO, ONTARIO, June 18, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”) announced the results from its annual general and special meeting of shareholders [...]

Pages